Center Organization and Infrastructure Unit

PS-OC组织了一个领导结构，以提供专业知识并全面支持所有倡议。这个 领导力由首席调查员Franziska Michor博士和高级联合调查员Eric组成 霍兰德医学博士。支持人员包括行政长官/教育主任、沙漠马-格兰特、 研究/项目经理，工商管理硕士，拉克尔·桑切斯，生物统计学家，米托·贡南，博士。PS-OC 领导和支持人员，也被称为行政部门，将共同努力，支持和 完成拟议的研究项目、核心、教育和培训单位、外联和传播 单位，以及试点和跨网络项目。PS-OC指导委员会(PSC)将每年举行会议，并将 由每个PS-OC的两名调查人员组成。首席调查员Franziska Michor博士和 高级联合调查员霍兰德博士将在PSC代表我们的PS-OC。 中心咨询委员会(CAC)将汇集在两个物理领域具有专业知识的调查人员 科学和基础科学组成一个由有投票权和无投票权的成员组成的小组。具体地说，CAC 将由下列有表决权的成员组成：两名自然科学成员，Franziska Michor(PD/PI)， 博士和Chris Sander博士；两名生物/临床成员William Pao，医学博士和Eric Holland， 医学博士/博士；以及NCI指定的有投票权的成员。无投票权的成员将包括至少两名外部成员 拥有广泛专业知识的顾问，一名外部顾问将在信号方面拥有广泛的熟练程度 转导、癌症生物学、项目管理和对与项目无关的肿瘤类型的关注 对PS-OC的影响。至少有一名其他外部顾问将精通一个或多个 以下：进化论、非进化性癌症系统、发育生物学、脑癌、肺癌 癌症、白血病、应用数学或工程/微制造。

The PS-OC has organized a leadership structure to provide expertise and fully support all initiatives. The leadership consists of the Principal Investigator, Franziska Michor, PhD, and the Senior Co-investigator, Eric Holland, MD, PhD. Support personnel consists of the Administrator/Education Director, Desert Horse-Grant, Research/Project Manager, Raquel Sanchez, MBA, and Biostatistician, Mithat Gonen, PhD. The PS-OC leadership and support personnel, also known as the Administration, will work collectively to support and accomplish the proposed research projects, core, educational and training unit, outreach and dissemination unit, and pilot and trans-network projects. The PS-OC Steering Committee (PSC) will meet annually and will consist of two investigators from each PS-OC. The Principal Investigator, Dr. Franziska Michor, and the Senior Co-investigator, Dr. Holland, will represent our PS-OC at the PSC. The Center Advisory Committee (CAC) will bring together investigators with expertise in both the physical sciences and the basic sciences to form a group of voting and non-voting members. Specifically, the CAC will be made up of the following voting members: two physical sciences members, Franziska Michor (PD/PI), PhD, and Chris Sander, PhD; two biological/clinical members, William Pao, MD/PhD, and Eric Holland, MD/PhD; and an NCI appointed voting member. Non-voting members will include at least two external advisors with a wide spectrum of expertise, One external advisor will have a broad proficiency in signal transduction, cancer biology, program management and a focus on a tumor type unaffiliated with the projects of the PS-OC. At least one other external advisor will have advanced knowledge of one or more of the following: evolutionary theory, non-evolutionary cancer systems, developmental biology, brain cancer, lung cancer, leukemia, applied mathematics or engineering/microfabrication.